Familial combined hyperlipidemia (FCHL, MIM-144250) is a common, multifactorial and heterogeneous dyslipidemia predisposing to premature coronary artery disease 1-2 and characterized by elevated plasma triglycerides, cholesterol, or both3 -4. We identified a mutant mouse strain, , that shares features with FCHL, including hypertriglyceridemia, hypercholesterolemia, elevated plasma apolipoprotein B and increased secretion of triglyceride-rich lipoproteins 5 . The hyperlipidemia results from spontaneous mutation at a locus, Hyplip1, on distal mouse chromosome 3 in a region syntenic with a 1q21-q23 FCHL locus identified in Finnish, German, Chinese and US families [6] [7] [8] . We fine-mapped Hyplip1 to roughly 160 kb, constructed a BAC contig and sequenced overlapping BACs to identify 13 candidate genes. We found substantially decreased mRNA expression for thioredoxin interacting protein (Txnip). Sequencing of the critical region revealed a Txnip nonsense mutation in HcB-19 that is absent in its normolipidemic parental strains. Txnip encodes a cytoplasmic protein that binds and inhibits thioredoxin, a major regulator of cellular redox state. The mutant mice have decreased CO 2 production but increased ketone body synthesis, suggesting that altered redox status down-regulates the citric-acid cycle, sparing fatty acids for triglyceride and ketone body production. These results reveal a new pathway of potential clinical significance that contributes to plasma lipid metabolism.
For fine-mapping, we constructed a large F2 intercross between HcB-19, a recombinant congenic strain that is 88% C3H/DiSnA (C3H) and 12% C57BL/10ScSnA (B10)9 -10, and the evolutionarily distant strain CAST/Ei. Approximately 2,700 (HcB-19 × CAST/Ei)F2 mice were generated and genotyped for 17 Hyplip1 region microsatellite markers. Triglycerides were significantly elevated in HcB-19 ( Fig. 1a) and yielded the highest lod score in our previously reported cross 5 . We therefore measured triglycerides for approximately one-third of (HcB-19 × CAST/Ei)F2 mice (Fig. 1b) . Because considerable phenotypic overlap made assigning recombinant animals to a particular genotypic class difficult, we searched for additional phenotypes.
In our previous cross of 183 (HcB-19 × B10)F2 animals, Hyplip1 was linked to plasma triglycerides, LDL+VLDL cholesterol, total cholesterol and free fatty acid (FFA) amounts with lod scores of 30.5, 22.4, 10.2 and 9.2, respectively, at peak marker D3Mit101 (ref. 5 and data not shown). As FFA levels were elevated and fatty acids are esterified to produce triglycerides or partially oxidized to form ketone bodies, we examined plasma levels of the predominant ketone body, β-hydroxybutyrate (β-HB). HcB-19 mice showed hyperketonemia, with β-HB levels increased approximately threefold (Fig. 1c) . Plasma β-HB levels segregated with the Hyplip1 locus in the (HcB-19 × CAST/Ei)F2 cross (Fig. 1d) , yielding a peak lod score of 219 at D3Mit101, whereas triglycerides reached a lod score of 90. Notably, the variability and overlap of β-HB levels between the genotypic classes were reduced as compared with triglycerides, making the assessment of Hyplip1 genotype for recombinant animals more definitive.
From approximately 2,700 (HcB-19 × CAST/Ei)F2 mice, we generated 184 animals with crossovers between D3Mit76 and D3Mit75 (Fig. 2a) . Initial analysis restricted Hyplip1 between D3Mit76 and D3Mit100 (ref. 11). We backcrossed recombinant animals to HcB-19 for progeny-testing to confirm the Hyplip1 genotype by analysis of backcross progeny that inherited the same Hyplip1 haplotype. To facilitate fine-mapping, we identified additional polymorphic SNP and microsatellite markers between HcB-19 and CAST/Ei (Fig. 2b) .
We assessed the probability that a particular haplotype carried the Hyplip1 mutation by logistic regression. We first analyzed the phenotype distribution of ketone body and triglyceride levels of nonrecombinant animals that were homozygous, heterozygous or wildtype with respect to Hyplip1 mutant alleles between D3Mit76 and D3Mit100. Using the resultant regression equations and sex-adjusted ketone body and triglyceride levels, we determined the predictive probability that the original recombinant was heterozygous [P(c/h)] and the predictive probabilities that backcross progeny with the same haplotype were homozygous with respect to Hyplip1 mutant alleles [P(h/h)]. On the basis of four critical recombinant animals and their backcross progeny (Fig. 3) , as well as additional recombinants and progeny (Table 1) , the critical region was narrowed to roughly 160 kb between D3Pds7 and D3Pds13. We therefore focused on this interval for physical mapping and sequencing.
To facilitate candidate gene identification, we constructed a BAC contig between D3Mit76 and D3Mit157 (Fig. 2b) . We used a 'chromosome walking' strategy to develop a complete contig containing 128 clones and covering 3 Mb. Four BACs representing a minimum tiling path across the critical region were subcloned and sequenced, revealing 13 genes (Fig. 2c ). Of these, only four (Txnip, Rbm8, Pex11b, and Itga10) were entirely within the maximal critical interval. We evaluated candidate genes by northern analysis and sequencing to identify possible differences between HcB-19 and its normolipidemic parental control.
Northern blot data revealed that mRNA amounts for Txnip were reduced approximately eightfold in HcB-19 (Fig. 4a) . No expression differences were observed for any other genes from the locus (data not shown). Sequencing Txnip RT-PCR products revealed a T→A transversion in HcB-19 at position 337 in the 1,456-bp cDNA (Fig. 4b) . This spontaneous point mutation changes a tyrosine (TAT) to a stop codon (TAA) at amino acid 97 in Txnip, which normally consists of 395 residues. Notably, this nonsense mutation in HcB-19 was absent in the C3H parental strain and 94 other strains of mice we examined ( Fig. 4b and data not shown). In addition, by comparing over 175 kb of fully aligned, contiguous genomic sequence from HcB-19 and C3H cosmid libraries, we observed only one coding difference, the Txnip nonsense mutation.
The gene Txnip contains eight exons spanning approximately 5 kb (Fig. 2d) . The Hyplip1 nonsense mutation occurs in exon 2 at codon 97 (Fig. 2d) . The Txnip transcript was fairly ubiquitously expressed in all tissues examined, with the highest abundance in heart, liver and kidney (Fig. 4c) . The decrease in Txnip mRNA in HcB-19 presumably results from nonsensemediated mRNA decay through RNA surveillance mechanisms for the detection and degradation of transcripts with premature stop codons [12] [13] .
The Hyplip1 nonsense mutation affects several aspects of lipid metabolism. In (HcB-19 × C57BL/6J)N4 congenic mice, plasma levels of TG, β-HB, TC, LDL+VLDL-C and FFA were significantly increased as compared with wildtype littermates (Fig. 5a-e) . In addition, in (HcB-19 × CAST/Ei)F2 animals, the Hyplip1 mutation was associated with increased plasma total cholesterol and LDL+VLDL cholesterol ( Fig. 5f-g ) as well as increased amounts of TG and β-HB (Fig. 1b,d) , consistent with our previous cross 5 . Plasma HDL cholesterol did not segregate with Hyplip1 (data not shown).
We previously showed that triglyceride secretion in vivo is increased roughly 70% in Hyplip1 mutant mice 5 . Consistent with this, we found an approximately 70% increase in triglyceride content of HcB-19 livers (Fig. 5i) . In addition, from isolated liver slices we observed that incorporation of 14 C-oleate into newly synthesized triglycerides was increased approximately 70% (Fig. 5j) .
Hyplip1 mice have increased plasma FFA levels (Fig. 5e,h ), which is predicted to increase the supply of exogenous FA to the liver because uptake is concentration-dependent. Hepatic FA are oxidized primarily in mitochondria, where they undergo complete oxidation to CO 2 via the TCA cycle, or partial oxidation to produce ketone bodies. As discussed, plasma β-HB was increased threefold in HcB-19 (Fig. 1c) . Consistent with these findings, we observed a twofold increase in ketone body synthesis in HcB-19 liver slices (Fig. 5k) . In contrast, CO 2 production was significantly decreased (Fig. 5l) , demonstrating reduced oxidation by the TCA cycle. Taken together, the data indicate that Hyplip1 results in increased FFA uptake by liver and decreased oxidation of FA by the TCA cycle, resulting in increased availability for triglyceride and ketone body synthesis. In addition, plasma lactate was significantly increased in HcB-19 mice (Fig. 5m) , whereas plasma pyruvate was decreased (Fig. 5n) 14 , these findings probably reflect an altered redox state resulting from the Hyplip1 mutation in Txnip.
The gene TXNIP was first identified from HL-60 cells stimulated to differentiate into monocytes/macrophages by 1,25-dihydroxyvitamin D 3 treatment 15 . More recent work revealed that both TXNIP and Txnip bind reduced thioredoxin (TXN) in vitro and in vivo and inhibit its reducing activity [16] [17] . In studies with partial proteins, amino acids 134-395 of Txnip were required for TXN binding and inhibition 17 . Because the Hyplip1 nonsense mutation occurs at residue 97, the truncated protein will be missing crucial amino acids, resulting in misregulation of thioredoxin.
Thioredoxin is a 12-kD thiol-oxidoreductase with many cellular functions, including cell activation 18 , cell growth 19 , apoptosis 20 , signal transduction 21 and gene expression 22 . Because Txnip inhibits thioredoxin, the Hyplip1 mutation may cause hyperlipidemia by affecting the Txn pathway, one of the major reducing systems 23 . Alterations in redox state could explain several aspects of the hyperlipidemic phenotype. For example, increased [NADH]: [NAD+] inhibits flux through the TCA cycle and results in decreased CO 2 production [24] [25] . As a result, more FA are available for the alternative oxidative pathway and for esterification.
Our results provide evidence of a new pathway with a profound influence on the regulation of lipid metabolism. Our data indicate the Hyplip1 mutation causes a decreased flux of FA through the TCA cycle, resulting in increased availability for ketogenesis and triglyceride synthesis. Further studies are warranted to elucidate the exact molecular mechanisms by which the Hyplip1 nonsense mutation in Txnip causes combined hyperlipidemia in HcB-19, as well as the potential role the human ortholog may have in FCHL or other metabolic disorders.
Methods

Mice and mouse husbandry
The development of the recombinant congenic mutant mouse strain HcB-19/Dem was described previously 5, 9 . Because HcB-19 animals were initially unavailable, we used (HcB-19 × BALB/c)F1 mice for breeding to CAST/Ei mice. We genotyped the resultant progeny for polymorphic markers D3Mit29, D3Mit76, D3Mit75 and D3Mit121 to exclude animals with BALB/c alleles within or near the Hyplip1 region. Animals with HcB-19 alleles were intercrossed to produce approximately 2,000 progeny that are essentially (HcB-19 × CAST/ Ei)F2 at the Hyplip1 locus. In addition, we generated approximately 700 (HcB-19 × CAST/ Ei)F2 mice. These two groups of F2 animals are referred to as '(HcB-19 × CAST/Ei)F2' mice. We constructed (HcB-19 × C57BL/6J)N4 congenic mice by backcrossing HcB-19 to C57BL/ 6J for four generations and selecting for HcB-19 alleles at markers D3Mit76 and D3Mit101 at each generation. Heterozygous N4 mice were intercrossed to obtain progeny that we screened to identify congenic mice homozygous with respect to the Hyplip1 nonsense mutation or wildtype. All mice were housed in groups of five or less animals per cage and maintained on a 12-h light-dark cycle at an ambient temperature of 23 °C. They were allowed ad libitum access to water and standard Purina Rodent Chow containing 4.5% fat (Ralston-Purina Co.).
Plasma lipid, ketone body and lactate determinations
Mice were fasted for 12 h before retro-orbital bleeding and were bled under isofluorane anesthesia 3-6 h after the beginning of the light cycle, with EDTA used as the anticoagulant. We determined plasma lipids as described previously 5 . We measured β-hydroxybutyrate levels in duplicate using a kit (#310-A, Sigma). We pre-chilled blood collection tubes on ice and centrifuged the samples within 5 min to remove erythrocytes to obtain accurate plasma lactate concentrations, which we measured in duplicate using a kit (#735-10, Sigma). For pyruvate determinations, we did not use EDTA, as whole blood was immediately deproteinized and the pyruvate measured using a kit (#726-UV, Sigma). For pyruvate measurements, we pre-chilled blood collection tubes with cold perchloric acid and kept the blood-precipitate mixture on ice for at least 5 min to ensure complete protein precipitation.
Statistical analysis
We analyzed linkage data and calculated lod scores and recombination distances using the Map Manager QT v.3.0 Program. As the triglyceride and ketone body levels of heterozygous mice overlapped with both wildtype and Hyplip1 mutant homozygous groups, recombinant mice were evaluated statistically using logistic regression. We calculated predictive probabilities using the logistic subroutine of the SAS program (Version 6.10, 1993, SAS Institute). Given the distribution of triglyceride and ketone body levels for each genotype from animals that were nonrecombinant between markers D3Mit76 and D3Mit100, we calculated logistic regression coefficients by using the ketone body values and the natural log of the triglyceride values (the natural log was used to normalize the data set.) We then used these logistic regression coefficients to calculate the probability that each parental recombinant animal was heterozygous and that each backcross progeny with the same haplotype was homozygous with respect to Hyplip1, given the sex-adjusted triglyceride and ketone body values. The predictive probabilities thus represent an estimate of the probability that a particular animal is heterozygous [P(c/h)] or homozygous [P(h/h)] for the Hyplip1 mutation based on its phenotype. The total cholesterol values were highly correlated with triglycerides in this sample (r=0.8025) and inclusion of total cholesterol levels did not significantly effect the predictive probability values after triglycerides were used in the prediction, although total cholesterol levels were significantly linked to the Hyplip1 locus (P<0.00005).
Radiation hybrid mapping and genotyping
We mapped markers and genes from the Hyplip1 region using the mouse/hamster T31 radiation hybrid panel (Research Genetics). All clone lines producing a breakpoint were typed in duplicate, as were any ambiguous typings. PCR and thermal cycling conditions were as recommended by the manufacturer. All mapping data are available at The Jackson Laboratory Mouse Radiation Hybrid database. We carried out automated genotyping of DNA microsatellite markers using fluorescent-labeled primers (Research Genetics) and ABI 377 machines according to standard protocols.
BAC contig and cosmid library construction
We identified BACs for the Hyplip1 region by hybridizing labeled PCR products from the Hyplip1 locus to filters from the RPCI-23 mouse BAC libraries (Children's Hospital, Oakland). Briefly, high-density filters with 10× coverage were hybridized with random-primed 32 Plabeled probes (1 × 10 6 cpm ml −1 hybridization solution). Ten to twenty PCR products were routinely pooled per hybridization. We pre-hybridized the filters for 1 h and then hybridized with labeled probes overnight (16-18 h) at 65 °C. We washed the filters at 65 °C for 4-6 times until all nonbound probe was essentially removed. The filters were then exposed to phosphor screens (Molecular Dynamics) for 2-24 h and analyzed on the Storm Image Analysis System (Molecular Dynamics). We interpreted the positions of positive clones according to the manufacturer's instructions, using transparent overlays as an orientation guide. The order of the markers was based on radiation hybrid mapping data and their presence or absence within each BAC clone bin. We sized BAC clones by pulsed-field gel electrophoresis. BAC ends were sequenced for primer design, PCR-amplified, and then used for chromosome walking and gap closure of the approximately 3-Mb contig we constructed between markers D3Mit76 and D3Mit157. For the construction of cosmid libraries, we used fresh livers from C3H and HcB-19 mice to prepare high-molecular weight genomic DNA embedded in agarose plugs. Genomic DNA was partially digested by MboI before ligation to the pFOS1 vector that was treated with AatII and BamH1 (New England Biolabs). The ligated mixture was packaged using the Gigpack III xl-11 (Stratagene) according to the manufacturer's protocol and transformed into DH10B competent cells. We determined the titer of roughly 200 clones and aliquoted them into 96-well format. Row and column pools were prepared for subsequent screening. We plated several hundred colonies from each positive well, picked 1,536 colonies into four 384-well microtiter plates and then transferred the cultures onto nylon membranes for hybridization to identify individual positive clones.
Sequencing and sequence data analysis
We extracted BAC DNA using a standard cesium chloride cushion 26 . For sequencing, a sublibrary in pUC18 was first constructed from each BAC clone. Briefly, we randomly sheared BAC DNA using a sonicator and end-filled with Klenow, then size-fractionated by agarose gel electrophoresis and collected fragments between 1.5 kb and 3.0 kb. We cloned the gel-purified fragments into SmaI-cut, bacterial alkaline phosphatase-treated pUC18. Ligation (Roche Rapid Ligation kit) and transformation of XL-10 competent cells (Stratagene) were carried out according to the manufacturer's instructions. We picked several thousand clones from each BAC library for high-throughput sequencing. We extracted plasmid DNA using the Qiagen Biorobot. Cycle sequencing was carried out using BigDye terminators (PE Applied Biosystems), purified on Centrisep spin columns in 96-well format and analyzed on an ABI 3700 capillary sequencer (PE Applied Biosystems). We purified PCR products using a kit (Qiagen) and used 30-60 ng for cycle sequencing. Raw sequence data were analyzed and assembled using PHRED and PHRAP, and then vector and repeat sequences were masked and high-quality sequence compared to available sequence databases.
Northern-blot analysis and RT-PCR
We isolated total RNA from liver with Trizol reagent (Life Technologies) according to the manufacturer's instructions. PolyA RNA was isolated using the Oligotex mRNA kit (Qiagen), and then 2 µg was resolved by electrophoresis in a denaturing agarose gel using the NorthernMax protocol and reagents (Ambion) and transferred to Brightstar-Plus membranes (Ambion) according to the manufacturer's instructions. We labeled DNA with 32 P-dCTP (Amersham Pharmacia Biotech) using a random-prime kit (Life Technologies). We hybridized and washed the filters according to the NorthernMax protocol, then exposed the filters overnight and imaged them using the Storm Image Analysis System (Molecular Dynamics). We carried out RT-PCR on total RNA using the Access RT-PCR kit (Promega).
Metabolism of 14 C-oleate in liver slices
After an overnight fast, mice were anesthetized with pentobarbital (50 mg kg −1 ) and the liver removed. We used a Staddie-Riggs microtome to obtain fresh liver slices (~0.5 mm thick) that were immediately weighed and incubated for 1 h under 95% O 2 :5% CO 2 in Krebs-Henseleit buffer containing 5.5 mM glucose and a 3% BSA/1 mM 14 C-oleic acid complex 27 . The final specific activity was 250,000 dpm µmol −1 . We determined 14 CO 2 production using hyamine hydroxide to trap the CO 2 and measuring the radioactive counts in a liquid scintillation spectrometer essentially as described 27 . The 14 C-oleic acid incorporation into ketone bodies and secreted triglycerides was determined in the liver slice incubations under similar conditions, except the cells were continuously gassed with 95% O 2 :5% CO 2 and no hyamine hydroxide was used. After the 40-min incubation, we removed the media for extraction of lipids and ketone bodies. We measured the radioactivity incorporated into ketone bodies after perchloric acid deproteinization as described 27 . The triglycerides were separated from media lipid extracts by thin layer chromatography, and the radioactivity in the band corresponding to triglycerides was determined as previously described 28 .
Primers
Primers for SNP and microsatellite markers are available upon request.
Genbank accession number
The accession number for the Hyplip1 cosmid sequence is AF449447. The accession number for the Txnip cDNA is AF173681. The predictive probability of heterozygosity, P(c/h), is shown for each parental recombinant, and the average predictive probability of homozygosity, P(h/h), is given for backcross progeny with the same haplotype. The R11 recombinant and all six backcross progeny with the same haplotype have lower β-HB and TG levels as compared with littermates homozygous with respect to HcB-19 alleles. R11 had a high probability of being heterozygous [P(c/h)=0.987] and the backcross progeny had a low probability of homozygosity with respect to Hyplip1 [P(h/h)=0.064], indicating that Hyplip1 is distal to D3Pds7. b, Recombinant R12 and 8 backcross progeny. All six backcross progeny with the parental haplotype have normal β-HB and TG levels, with a low probability of homozygosity with respect to Hyplip1 [P(h/h)=0.156]. Thus, Hyplip1 lies proximal to D3Pds13. c, Recombinant R13 and 3 backcross progeny. As shown, R13 carries Hyplip1 alleles proximal to D3Pds13. Backcross progeny carrying this crossover have increased amounts of β-HB and TG, indicating homozygosity for Hyplip1 with a high probability [P(h/h)=0.959], giving further evidence that Hyplip1 is proximal to D3Pds13. d, Recombinant R14, six backcross progeny, and 90 animals obtained from intercrossing backcross progeny with the crossover breakpoint. R14 had a high probability of being heterozygous [P(c/h)=0.816]. Backcross progeny with the same haplotype have increased amounts of β-HB and TG, indicating homozygosity with respect to Hyplip1 [P(h/h)=0.955].
When these mice are intercrossed, all resultant progeny have increased β-HB and TG levels (the average ± s.e.m. for each genotypic group is shown), providing additional evidence for placing the distal boundary for Hyplip1 at D3Pds13.
Fig. 4.
Expression and sequence analysis of Txnip. a, Northern blot data revealing decreased mRNA expression for Txnip in HcB-19 as compared with the C3H parental control strain. Expression levels for another gene from the Hyplip1 region, Pja1l, serve as a locus and RNA loading control. b, Sequence analysis of HcB-19 and C3H mice reveals a T→A transversion mutation present in HcB-19 that is absent from the C3H strain from which it was derived. The sequence chromatograms from HcB-19 and C3H mice are shown, as well as the DNA sequence data from three HcB-19 and three C3H mice. c, Northern-blot analysis of the Txnip transcript in various tissues reveals detectable expression in brain, spleen, lung, liver, skeletal muscle, kidney and testis, with the highest abundance occurring in heart. j, Dpm of 14 C-oleic acid per g of liver tissue in newly-synthesized triglycerides secreted from liver slices isolated from fasted HcB- 19 
